251 related articles for article (PubMed ID: 11806712)
1. Synthesis and biological activity of a novel class of small molecular weight peptidomimetic competitive inhibitors of protein tyrosine phosphatase 1B.
Larsen SD; Barf T; Liljebris C; May PD; Ogg D; O'Sullivan TJ; Palazuk BJ; Schostarez HJ; Stevens FC; Bleasdale JE
J Med Chem; 2002 Jan; 45(3):598-622. PubMed ID: 11806712
[TBL] [Abstract][Full Text] [Related]
2. Investigation of potential bioisosteric replacements for the carboxyl groups of peptidomimetic inhibitors of protein tyrosine phosphatase 1B: identification of a tetrazole-containing inhibitor with cellular activity.
Liljebris C; Larsen SD; Ogg D; Palazuk BJ; Bleasdale JE
J Med Chem; 2002 Apr; 45(9):1785-98. PubMed ID: 11960490
[TBL] [Abstract][Full Text] [Related]
3. Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action.
Bleasdale JE; Ogg D; Palazuk BJ; Jacob CS; Swanson ML; Wang XY; Thompson DP; Conradi RA; Mathews WR; Laborde AL; Stuchly CW; Heijbel A; Bergdahl K; Bannow CA; Smith CW; Svensson C; Liljebris C; Schostarez HJ; May PD; Stevens FC; Larsen SD
Biochemistry; 2001 May; 40(19):5642-54. PubMed ID: 11341829
[TBL] [Abstract][Full Text] [Related]
4. Modification of the N-terminus of peptidomimetic protein tyrosine phosphatase 1B (PTP1B) inhibitors: identification of analogues with cellular activity.
Larsen SD; Stevens FC; Lindberg TJ; Bodnar PM; O'Sullivan TJ; Schostarez HJ; Palazuk BJ; Bleasdale JE
Bioorg Med Chem Lett; 2003 Mar; 13(5):971-5. PubMed ID: 12617932
[TBL] [Abstract][Full Text] [Related]
5. In silico structure-based design of a potent and selective small peptide inhibitor of protein tyrosine phosphatase 1B, a novel therapeutic target for obesity and type 2 diabetes mellitus: a computer modeling approach.
Rao GS; Ramachandran MV; Bajaj JS
J Biomol Struct Dyn; 2006 Feb; 23(4):377-84. PubMed ID: 16363874
[TBL] [Abstract][Full Text] [Related]
6. Discovery and SAR of a novel selective and orally bioavailable nonpeptide classical competitive inhibitor class of protein-tyrosine phosphatase 1B.
Andersen HS; Olsen OH; Iversen LF; Sørensen AL; Mortensen SB; Christensen MS; Branner S; Hansen TK; Lau JF; Jeppesen L; Moran EJ; Su J; Bakir F; Judge L; Shahbaz M; Collins T; Vo T; Newman MJ; Ripka WC; Møller NP
J Med Chem; 2002 Sep; 45(20):4443-59. PubMed ID: 12238924
[TBL] [Abstract][Full Text] [Related]
7. The structural basis for the selectivity of benzotriazole inhibitors of PTP1B.
Scapin G; Patel SB; Becker JW; Wang Q; Desponts C; Waddleton D; Skorey K; Cromlish W; Bayly C; Therien M; Gauthier JY; Li CS; Lau CK; Ramachandran C; Kennedy BP; Asante-Appiah E
Biochemistry; 2003 Oct; 42(39):11451-9. PubMed ID: 14516196
[TBL] [Abstract][Full Text] [Related]
8. Structure-based design and discovery of protein tyrosine phosphatase inhibitors incorporating novel isothiazolidinone heterocyclic phosphotyrosine mimetics.
Combs AP; Yue EW; Bower M; Ala PJ; Wayland B; Douty B; Takvorian A; Polam P; Wasserman Z; Zhu W; Crawley ML; Pruitt J; Sparks R; Glass B; Modi D; McLaughlin E; Bostrom L; Li M; Galya L; Blom K; Hillman M; Gonneville L; Reid BG; Wei M; Becker-Pasha M; Klabe R; Huber R; Li Y; Hollis G; Burn TC; Wynn R; Liu P; Metcalf B
J Med Chem; 2005 Oct; 48(21):6544-8. PubMed ID: 16220970
[TBL] [Abstract][Full Text] [Related]
9. Cellular effects of small molecule PTP1B inhibitors on insulin signaling.
Xie L; Lee SY; Andersen JN; Waters S; Shen K; Guo XL; Moller NP; Olefsky JM; Lawrence DS; Zhang ZY
Biochemistry; 2003 Nov; 42(44):12792-804. PubMed ID: 14596593
[TBL] [Abstract][Full Text] [Related]
10. Novel benzofuran and benzothiophene biphenyls as inhibitors of protein tyrosine phosphatase 1B with antihyperglycemic properties.
Malamas MS; Sredy J; Moxham C; Katz A; Xu W; McDevitt R; Adebayo FO; Sawicki DR; Seestaller L; Sullivan D; Taylor JR
J Med Chem; 2000 Apr; 43(7):1293-310. PubMed ID: 10753467
[TBL] [Abstract][Full Text] [Related]
11. Monocyclic thiophenes as protein tyrosine phosphatase 1B inhibitors: capturing interactions with Asp48.
Wan ZK; Lee J; Xu W; Erbe DV; Joseph-McCarthy D; Follows BC; Zhang YL
Bioorg Med Chem Lett; 2006 Sep; 16(18):4941-5. PubMed ID: 16806920
[TBL] [Abstract][Full Text] [Related]
12. Discovery of a potent, selective protein tyrosine phosphatase 1B inhibitor using a linked-fragment strategy.
Szczepankiewicz BG; Liu G; Hajduk PJ; Abad-Zapatero C; Pei Z; Xin Z; Lubben TH; Trevillyan JM; Stashko MA; Ballaron SJ; Liang H; Huang F; Hutchins CW; Fesik SW; Jirousek MR
J Am Chem Soc; 2003 Apr; 125(14):4087-96. PubMed ID: 12670229
[TBL] [Abstract][Full Text] [Related]
13. Benzothiazole benzimidazole (S)-isothiazolidinone derivatives as protein tyrosine phosphatase-1B inhibitors.
Sparks RB; Polam P; Zhu W; Crawley ML; Takvorian A; McLaughlin E; Wei M; Ala PJ; Gonneville L; Taylor N; Li Y; Wynn R; Burn TC; Liu PC; Combs AP
Bioorg Med Chem Lett; 2007 Feb; 17(3):736-40. PubMed ID: 17097290
[TBL] [Abstract][Full Text] [Related]
14. Structural basis for inhibition of the protein tyrosine phosphatase 1B by phosphotyrosine peptide mimetics.
Groves MR; Yao ZJ; Roller PP; Burke TR; Barford D
Biochemistry; 1998 Dec; 37(51):17773-83. PubMed ID: 9922143
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological activity of a novel class of pyridazine analogues as non-competitive reversible inhibitors of protein tyrosine phosphatase 1B (PTP1B).
Liljebris C; Martinsson J; Tedenborg L; Williams M; Barker E; Duffy JE; Nygren A; James S
Bioorg Med Chem; 2002 Oct; 10(10):3197-212. PubMed ID: 12150865
[TBL] [Abstract][Full Text] [Related]
16. Structural insights into the design of nonpeptidic isothiazolidinone-containing inhibitors of protein-tyrosine phosphatase 1B.
Ala PJ; Gonneville L; Hillman M; Becker-Pasha M; Yue EW; Douty B; Wayland B; Polam P; Crawley ML; McLaughlin E; Sparks RB; Glass B; Takvorian A; Combs AP; Burn TC; Hollis GF; Wynn R
J Biol Chem; 2006 Dec; 281(49):38013-21. PubMed ID: 17028182
[TBL] [Abstract][Full Text] [Related]
17. PTP1b Inhibition, A Promising Approach for the Treatment of Diabetes Type II.
Eleftheriou P; Geronikaki A; Petrou A
Curr Top Med Chem; 2019; 19(4):246-263. PubMed ID: 30714526
[TBL] [Abstract][Full Text] [Related]
18. Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics.
Jia Z; Ye Q; Dinaut AN; Wang Q; Waddleton D; Payette P; Ramachandran C; Kennedy B; Hum G; Taylor SD
J Med Chem; 2001 Dec; 44(26):4584-94. PubMed ID: 11741477
[TBL] [Abstract][Full Text] [Related]
19. Development of a robust scintillation proximity assay for protein tyrosine phosphatase 1B using the catalytically inactive (C215S) mutant.
Skorey KI; Kennedy BP; Friesen RW; Ramachandran C
Anal Biochem; 2001 Apr; 291(2):269-78. PubMed ID: 11401301
[TBL] [Abstract][Full Text] [Related]
20. Potent benzimidazole sulfonamide protein tyrosine phosphatase 1B inhibitors containing the heterocyclic (S)-isothiazolidinone phosphotyrosine mimetic.
Combs AP; Zhu W; Crawley ML; Glass B; Polam P; Sparks RB; Modi D; Takvorian A; McLaughlin E; Yue EW; Wasserman Z; Bower M; Wei M; Rupar M; Ala PJ; Reid BM; Ellis D; Gonneville L; Emm T; Taylor N; Yeleswaram S; Li Y; Wynn R; Burn TC; Hollis G; Liu PC; Metcalf B
J Med Chem; 2006 Jun; 49(13):3774-89. PubMed ID: 16789735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
